These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33013203)

  • 1. Cost-utility analysis of cardiovascular outpatient rehabilitation care and spa treatment care for patients with heart disease.
    Gajdoš O; Kamenský V; Doskočilová K; Caithamlová M; Kubátová I
    Cost Eff Resour Alloc; 2020; 18():39. PubMed ID: 33013203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-Utility Analysis of Home Mechanical Ventilation in Patients with Amyotrophic Lateral Sclerosis.
    Gajdoš O; Rožánek M; Donin G; Kamenský V
    Healthcare (Basel); 2021 Feb; 9(2):. PubMed ID: 33535635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study.
    Knapp M; Windmeijer F; Brown J; Kontodimas S; Tzivelekis S; Haro JM; Ratcliffe M; Hong J; Novick D;
    Pharmacoeconomics; 2008; 26(4):341-58. PubMed ID: 18370568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "As du Coeur" study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease.
    Bailly L; Mossé P; Diagana S; Fournier M; d'Arripe-Longueville F; Diagana O; Gal J; Grebet J; Moncada M; Domerego JJ; Radel R; Fabre R; Fuch A; Pradier C
    BMC Cardiovasc Disord; 2018 Dec; 18(1):225. PubMed ID: 30522438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Evaluation of Rehabilitation Services for Inpatients with Stroke in Thailand: A Prospective Cohort Study.
    Khiaocharoen O; Pannarunothai S; Riewpaiboon W; Ingsrisawang L; Teerawattananon Y
    Value Health Reg Issues; 2012 May; 1(1):29-35. PubMed ID: 29702822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT.
    King AJ; Fernie G; Hudson J; Kernohan A; Azuara-Blanco A; Burr J; Homer T; Shabaninejad H; Sparrow JM; Garway-Heath D; Barton K; Norrie J; McDonald A; Vale L; MacLennan G
    Health Technol Assess; 2021 Nov; 25(72):1-158. PubMed ID: 34854808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial.
    Van Tubergen A; Boonen A; Landewé R; Rutten-Van Mölken M; Van Der Heijde D; Hidding A; Van Der Linden S
    Arthritis Rheum; 2002 Oct; 47(5):459-67. PubMed ID: 12382292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Cost-Effectiveness Using Alternative Preference-Based Scores and Within-Trial Methods: Exploring the Dynamics of the Quality-Adjusted Life-Year Using the EQ-5D 5-Level Version and Recovering Quality of Life Utility Index.
    Franklin M; Hunter RM; Enrique A; Palacios J; Richards D
    Value Health; 2022 Jun; 25(6):1018-1029. PubMed ID: 35667775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness and Value of Information of Cabozantinib Treatment for Patients with Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea.
    Kim S; Han S; Kim H; Suh HS
    Appl Health Econ Health Policy; 2021 Jul; 19(4):545-555. PubMed ID: 33651367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China.
    Huang L; Peng X; Sun L; Zhang D
    Cost Eff Resour Alloc; 2023 Jun; 21(1):37. PubMed ID: 37277820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Cardiac Telerehabilitation With Relapse Prevention for the Treatment of Patients With Coronary Artery Disease in the Netherlands.
    Brouwers RWM; van der Poort EKJ; Kemps HMC; van den Akker-van Marle ME; Kraal JJ
    JAMA Netw Open; 2021 Dec; 4(12):e2136652. PubMed ID: 34854907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdiscectomy Is More Cost-effective Than a 6-Month Nonsurgical Care Regimen for Chronic Radiculopathy.
    Glennie RA; Urquhart JC; Koto P; Rasoulinejad P; Taylor D; Sequeira K; Miller T; Watson J; Rosedale R; Bailey SI; Gurr KR; Siddiqi F; Bailey CS
    Clin Orthop Relat Res; 2022 Mar; 480(3):574-584. PubMed ID: 34597280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of operative versus nonoperative treatment of a humeral shaft fracture: economic analyses alongside a multicenter prospective cohort study (HUMMER).
    Van Bergen SH; Van Lieshout EMM; Mahabier KC; Geraerds AJLM; Polinder S; Den Hartog D; Verhofstad MHJ;
    Eur J Trauma Emerg Surg; 2023 Apr; 49(2):929-938. PubMed ID: 36480054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang F; Devlin N; Luo N
    Value Health; 2019 Jan; 22(1):45-49. PubMed ID: 30661633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Utility Analysis of Fixed-Dose Combination of Indacaterol Acetate Glycopyrronium Bromide and Mometasone Furoate as a Maintenance Treatment in Adult Patients with Asthma Not Adequately Controlled with a Maintenance Combination of a Long-Acting Beta-Agonist and a High Dose of an Inhaled Corticosteroid Who Experienced One or More Asthma Exacerbations in the Previous Year.
    Mangia PP; Gallo O; Ritrovato D; Pradelli L
    Clin Drug Investig; 2021 Sep; 41(9):785-794. PubMed ID: 34333742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of combined cognitive and vocational rehabilitation in patients with mild-to-moderate TBI: results from a randomized controlled trial.
    Howe EI; Andelic N; Fure SCR; Røe C; Søberg HL; Hellstrøm T; Spjelkavik Ø; Enehaug H; Lu J; Ugelstad H; Løvstad M; Aas E
    BMC Health Serv Res; 2022 Feb; 22(1):185. PubMed ID: 35151285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for degenerative cervical myelopathy: a patient-centered quality of life and health economic evaluation.
    Witiw CD; Tetreault LA; Smieliauskas F; Kopjar B; Massicotte EM; Fehlings MG
    Spine J; 2017 Jan; 17(1):15-25. PubMed ID: 27793760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacubitril-valsartan for the treatment of hypertension in China: A cost-utility analysis based on meta-analysis of randomized controlled trials.
    Lou Y; Yu Y; Liu J; Huang J
    Front Public Health; 2022; 10():959139. PubMed ID: 36062091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.